This is a competitive renewal for R01 AG 029672, which applied modern psychometric methods to neuropsychological data collected by the Alzheimer's Disease Neuroimaging Initiative (ADNI). This competitive renewal proposes to analyze data from ADNI and from the Australian Imaging, Biomarkers, and Lifestyles of Ageing (AIBL) study using state-of-the-art psychometric approaches to address substantively important questions in Alzheimer's disease (AD) research. This project in many ways serves as a bridge between fields that do not often talk with each other: modern psychometrics and cognitive neuroscience applied to neurodegenerative conditions. The investigators propose to tackle two important problems in AD research: improving the ability to detect preclinical disease at the earliest stages (Aim 1) and understanding the clinical relevance of heterogeneity in the presentation of AD (Aim 2). Advances in modern psychometrics have the potential to optimize understanding of these critical questions by translating clinical insights into quantitative analytic approaches. The investigators have a tradition of disseminating their tools to the broader research community and propose to continue this tradition with a dissemination aim (Aim 3). Support for the next cycle of funding for this project will ensure continued scientific leadership bridging modern psychometrics and cognitive neuroscience.

Public Health Relevance

Alzheimer's disease is an important threat to the quality of life of older adults and their families and the U.S. and world economies. This project proposes to analyze extensive cognitive, neuroimaging, and fluid biomarker data from the Alzheimer's Disease Neuroimaging Initiative (ADNI) and from the Australian Imaging Biomarkers and Lifestyles of Ageing (AIBL) studies to optimize psychometric strategies to address substantively important questions on Alzheimer's disease and the aging brain. These investigations are concordant with the mission of the National Institute on Aging.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
2R01AG029672-06A1
Application #
9236950
Study Section
Adult Psychopathology and Disorders of Aging Study Section (APDA)
Program Officer
Hsiao, John
Project Start
2007-09-15
Project End
2022-03-31
Budget Start
2017-04-15
Budget End
2018-03-31
Support Year
6
Fiscal Year
2017
Total Cost
$670,470
Indirect Cost
$168,850
Name
University of Washington
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Crane, Paul K; Trittschuh, Emily; Mukherjee, Shubhabrata et al. (2017) Incidence of cognitively defined late-onset Alzheimer's dementia subgroups from a prospective cohort study. Alzheimers Dement 13:1307-1316
Erosheva, Elena A; Curtis, S McKay (2017) Dealing with Reflection Invariance in Bayesian Factor Analysis. Psychometrika 82:295-307
Dadar, Mahsa; Maranzano, Josefina; Misquitta, Karen et al. (2017) Performance comparison of 10 different classification techniques in segmenting white matter hyperintensities in aging. Neuroimage 157:233-249
Deters, Kacie D; Nho, Kwangsik; Risacher, Shannon L et al. (2017) Genome-wide association study of language performance in Alzheimer's disease. Brain Lang 172:22-29
Dmitrieva, Natalia O; Fyffe, Denise; Mukherjee, Shubhabrata et al. (2015) Demographic characteristics do not decrease the utility of depressive symptoms assessments: examining the practical impact of item bias in four heterogeneous samples of older adults. Int J Geriatr Psychiatry 30:88-96
Luo, Jingqin; D'Angela, Gina; Gao, Feng et al. (2015) Bivariate correlation coefficients in family-type clustered studies. Biom J 57:1084-109
Fieo, Robert; Mukherjee, Shubhabrata; Dmitrieva, Natalia O et al. (2015) Differential item functioning due to cognitive status does not impact depressive symptom measures in four heterogeneous samples of older adults. Int J Geriatr Psychiatry 30:911-8
Mukherjee, Shubhabrata; Kim, Sungeun; Ramanan, Vijay K et al. (2014) Gene-based GWAS and biological pathway analysis of the resilience of executive functioning. Brain Imaging Behav 8:110-8
Xiong, Chengjie; Luo, Jingqin; Gao, Feng et al. (2014) Optimizing parameters in clinical trials with a randomized start or withdrawal design. Comput Stat Data Anal 69:101-113
Dong, Tuochuan; Kang, Le; Hutson, Alan et al. (2014) Confidence interval estimation of the difference between two sensitivities to the early disease stage. Biom J 56:270-86

Showing the most recent 10 out of 44 publications